APPLICATION
ANDA212482
TYPE
ANDA
ORIGINAL APPROVAL
2021-07-27
LATEST ACTION
2021-07-27
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription
Products
LIDOCAINE AND PRILOCAINEPrescription
LIDOCAINE 2.5%, PRILOCAINE 2.5% · CREAM · TOPICAL
Approval history
2021-07-27UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.